ABCC1 p.Asp1454Leu
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 10781583
[PubMed]
Hou Y et al: "Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1."
No.
Sentence
Comment
33
Stable cell lines expressing wild-type and mutant MRP1s, K684L, D792L/D793L, K1333L, and D1454L/E1455L, were generated by using procedures described previously (11).
X
ABCC1 p.Asp1454Leu 10781583:33:89
status: NEW205 Fig. 5C shows that although labeling by N3[␣-32 P]ATP was not abolished by the mutations, it was greatly reduced: K684L was ϳ10% of wild-type; K1333L, ϳ5%; D1454L/D1455L, ϳ15%.
X
ABCC1 p.Asp1454Leu 10781583:205:175
status: NEW207 Fig. 5D demonstrates that labeling of K684L by N3[␥-32 P]ATP was almost eliminated and labeling of K1333L and D1454L/E1455L were decreased to ϳ10% and ϳ15% of the wild-type levels, respectively.
X
ABCC1 p.Asp1454Leu 10781583:207:117
status: NEW232 Lane 1, 10 g of wild-type MRP1; lane 2, 20 g of K684L; lane 3, 10 g of K1333L; lane 4, 10 g of D1454L/ E1455L.
X
ABCC1 p.Asp1454Leu 10781583:232:127
status: NEW234 Lane 1, 10 g of wild-type MRP1; lane 2, 20 g of K684L; lane 3, 10 g of K1333L; lane 4, 10 g of D1454L/ E1455L.
X
ABCC1 p.Asp1454Leu 10781583:234:127
status: NEW235 E, ATP-dependent LTC4 uptake by membrane vesicles containing wild-type (closed diamonds) and mutant MRPs: NBD1 Walker A lysine mutant K684L (open circles), NBD2 Walker A lysine mutant K1333L (open square), NBD2 Walker B aspartate mutant D1454L/ E1455L (closed circles).
X
ABCC1 p.Asp1454Leu 10781583:235:237
status: NEW
PMID: 11741902
[PubMed]
Hou YX et al: "ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain."
No.
Sentence
Comment
50
Stable cell lines expressing wild-type and mutant MRP1s, K684L, D792A, K1333L, and D1454L/E1455L were established previously (2, 31).
X
ABCC1 p.Asp1454Leu 11741902:50:83
status: NEW117 Essentially the stimulation was much reduced in the NBD1 mutants, K684L and D792A (Fig. 4, C and D), and in the NBD2 mutants, K1333L and D1454L/E1455L (Fig. 4, E and F), and the stimulation effects were shifted to higher ATP concentrations (Fig. 4, C-F).
X
ABCC1 p.Asp1454Leu 11741902:117:137
status: NEW118 Trypsin digestion of either [␣-32 P]8-N3ATP or [␣-32 P]8N3ADP-labeled K1333L and D1454L/E1455L proved that the mutated NBD2 fragment can still be labeled (data not shown).
X
ABCC1 p.Asp1454Leu 11741902:118:95
status: NEW173 Lane 1, 10 g of wild-type MRP1; lane 2, 15 g of K684L; lane 3, 20 g of D792A; lane 4, 10 g of K1333L; lane 5, 10 g of D1454L/E1455L.
X
ABCC1 p.Asp1454Leu 11741902:173:158
status: NEW175 The results for K684L and D792A are the average of three independent experiments and for K1333L and D1454L/E1455L are the average of two independent experiments. C, influence of ATP on the [␣-32 P]8-N3ADP labeling of K684L.
X
ABCC1 p.Asp1454Leu 11741902:175:100
status: NEW180 F, influence of ATP on the [␣-32 P]8-N3ADP labeling of D1454L/E1455L.
X
ABCC1 p.Asp1454Leu 11741902:180:62
status: NEW181 10 g of D1454L/E1455L was labeled in the presence of varying amounts of ATP indicated above each lane.
X
ABCC1 p.Asp1454Leu 11741902:181:16
status: NEW
PMID: 15737336
[PubMed]
Yang R et al: "Nucleotide dissociation from NBD1 promotes solute transport by MRP1."
No.
Sentence
Comment
159
Interestingly, this result is also similar to that of the double mutant D1454L/E1455L [28] including the mutations of the D1454 residue in the Walker B motif and the putative catalytic base E1455 residue directly adjacent to the D1454, implying that the mutation of the putative catalytic base E1455 to a non-acidic amino acid affecting ATP hydrolysis [43] has the same effects as the D1454L/E1455L double mutant affecting ATP binding [28] and hydrolysis.
X
ABCC1 p.Asp1454Leu 15737336:159:72
status: NEWX
ABCC1 p.Asp1454Leu 15737336:159:385
status: NEW
PMID: 16442101
[PubMed]
Frelet A et al: "Insight in eukaryotic ABC transporter function by mutation analysis."
No.
Sentence
Comment
160
D792A (NBD1) and D1454L/E1455L (NBD2) diminished nucleotide-binding abilities rather than completely abolishing binding [100].
X
ABCC1 p.Asp1454Leu 16442101:160:17
status: NEW
PMID: 18088596
[PubMed]
Yang R et al: "The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function."
No.
Sentence
Comment
253
In addition, substitutions of the Walker B motif D1454 and E1455 in NBD2 of MRP1 with a leucine residue (D1454L/E1455L) also did not cause misfolding of the protein [20].
X
ABCC1 p.Asp1454Leu 18088596:253:105
status: NEW254 In order to rule out the possibility that the double mutant D1454L/E1455L might rescue the misfolding caused by D14 54L mutation, we have made single mutants including D1454L, D1454N, S1334A, S1334T, S1334C, S1334H, S1334D and S1334N.
X
ABCC1 p.Asp1454Leu 18088596:254:60
status: NEWX
ABCC1 p.Asp1454Leu 18088596:254:168
status: NEW261 It is also true for the corresponding mutations in Walker B motif of NBD2 in MRP1, such as D1454L (manuscript in preparation) and D1454N [46], have a significant effect on the ATP-dependent LTC4 transport.
X
ABCC1 p.Asp1454Leu 18088596:261:91
status: NEW
PMID: 18636743
[PubMed]
Yang R et al: "Interaction between the bound Mg.ATP and the Walker A serine residue in NBD2 of multidrug resistance-associated protein MRP1 plays a crucial role for the ATP-dependent leukotriene C4 transport."
No.
Sentence
Comment
12
In contrast, however, substitution of the corresponding Walker B D1454 in NBD2 with the hydrophobic residue leucine (D1454L/E1455L) did not cause misfolding of the mutated MRP1 protein (8), suggesting distinct structures in NBD1 and NBD2 of MRP1.
X
ABCC1 p.Asp1454Leu 18636743:12:117
status: NEW166 Indeed, elimination of the carboxyl group at D1454, such as D1454L/E1455L (8), had no effect on the protein folding and processing.
X
ABCC1 p.Asp1454Leu 18636743:166:60
status: NEW
PMID: 19285030
[PubMed]
Wan L et al: "Characterization of the ATPase activity of a novel chimeric fusion protein consisting of the two nucleotide binding domains of MRP1."
No.
Sentence
Comment
163
Among the NBD1-GST-NBD2 mutants, K684L in Walker A of NBD1, K1333L in Walker A of NBD2, and D1454L/E1455L in Walker B of NBD2 were expressed mainly as inclusion bodies in E. coli, and only the E1455Q mutant was expressed in a sufficient quantity of soluble protein to allow activity analysis.
X
ABCC1 p.Asp1454Leu 19285030:163:92
status: NEW
PMID: 11469806
[PubMed]
Cui L et al: "Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformational maturation."
No.
Sentence
Comment
42
Stable cell lines expressing wild-type and mutant MRP1s, K684L, D792L/D793L, K1333L, and D1454L/E1455L were established previously (8).
X
ABCC1 p.Asp1454Leu 11469806:42:89
status: NEW147 This was also true in the case of D793L (Fig. 5E) and mutations of the Walker A lysine residues in both NBDs (Fig. 5B, K684L, and Fig. 5G, K1333L), where the protein matured normally as did a variant in which the Walker B aspartate in NBD2 was mutated (Fig. 5H, D1454L/ E1455L).
X
ABCC1 p.Asp1454Leu 11469806:147:262
status: NEW174 Since hydrolysis is believed to drive MRP1 transport it would be expected that the mature D792A protein would not be capable of active transport.
X
ABCC1 p.Asp1454Leu 11469806:174:286
status: NEW175 The data in Fig. 7 confirm this expectation, i.e., there is not significantly more ATP-dependent LTC4 uptake by vesicles containing D792A protein that does mature than by the other variants that do not mature (Fig. 7, D792L and D792L/D793L), nor by the NBD2 mutants (Fig. 7, K1333L and D1454L/E1455L) that do mature but have difficulties to hydrolyze ATP and to trap the hydrolysis product, ADP (8).
X
ABCC1 p.Asp1454Leu 11469806:175:286
status: NEW208 (G) K1333L, 0.3 g protein in each lane.
X
ABCC1 p.Asp1454Leu 11469806:208:4
status: NEW209 (H) D1454L/E1455L, 0.3 g protein in each lane.
X
ABCC1 p.Asp1454Leu 11469806:209:4
status: NEW146 This was also true in the case of D793L (Fig. 5E) and mutations of the Walker A lysine residues in both NBDs (Fig. 5B, K684L, and Fig. 5G, K1333L), where the protein matured normally as did a variant in which the Walker B aspartate in NBD2 was mutated (Fig. 5H, D1454L/ E1455L).
X
ABCC1 p.Asp1454Leu 11469806:146:262
status: NEW